Cargando…
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
Recurrence is a major cause of death among BRCA1/2 mutation carriers with breast (BrCa) and ovarian cancers (OvCa). Herein we perform multi-omic sequencing on 67 paired primary and recurrent BrCa and OvCa from 27 BRCA1/2 mutation carriers to identify potential recurrence-specific drivers. PARP1 ampl...
Autores principales: | Shah, Jennifer B., Pueschl, Dana, Wubbenhorst, Bradley, Fan, Mengyao, Pluta, John, D’Andrea, Kurt, Hubert, Anna P., Shilan, Jake S., Zhou, Wenting, Kraya, Adam A., Llop Guevara, Alba, Ruan, Catherine, Serra, Violeta, Balmaña, Judith, Feldman, Michael, Morin, Pat J., Nayak, Anupma, Maxwell, Kara N., Domchek, Susan M., Nathanson, Katherine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640723/ https://www.ncbi.nlm.nih.gov/pubmed/36344544 http://dx.doi.org/10.1038/s41467-022-34523-y |
Ejemplares similares
-
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
Clinical consequences of BRCA2 hypomorphism
por: Castells-Roca, Laia, et al.
Publicado: (2021) -
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
por: Wang, Yifan, et al.
Publicado: (2019) -
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer
por: Maxwell, Kara N., et al.
Publicado: (2014)